摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(3R,4R)-l-tert-butyl-4-carboxy-3-(2,4-difluoro-phenyl)pyrrolidine | 757974-18-8

中文名称
——
中文别名
——
英文名称
(3R,4R)-l-tert-butyl-4-carboxy-3-(2,4-difluoro-phenyl)pyrrolidine
英文别名
(3R,4R)-1-tert-butyl-3-(2,4-difluorophenyl)piperidine-4-carboxylic acid
(3R,4R)-l-tert-butyl-4-carboxy-3-(2,4-difluoro-phenyl)pyrrolidine化学式
CAS
757974-18-8
化学式
C16H21F2NO2
mdl
——
分子量
297.345
InChiKey
PPMHTSCCCOAQDO-OLZOCXBDSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.6
  • 重原子数:
    21
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.56
  • 拓扑面积:
    40.5
  • 氢给体数:
    1
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] BICYCLIC PIPERIDINE DERIVATIVES AS MELANOCORTIN-4 RECEPTOR AGONISTS<br/>[FR] DERIVES DE PIPERIDINE BICYCLIQUES UTILISES COMME AGONISTES DU RECEPTEUR 4 DE LA MELANOCORTINE
    申请人:MERCK & CO INC
    公开号:WO2004087159A1
    公开(公告)日:2004-10-14
    Certain novel bicyclic N-acylated piperidine derivatives are agonists of the human melanocortin receptor(s) and, in particular, are selective agonists of the human melanocortin-4 receptor (MC-4R). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the activation of MC-4R, such as obesity, diabetes, sexual dysfunction, including erectile dysfunction and female sexual dysfunction.
    某些新颖的双环N-酰化哌啶衍生物是人类黑色素皮质素受体的激动剂,特别是人类黑色素皮质素-4受体(MC-4R)的选择性激动剂。因此,它们对于治疗、控制或预防对MC-4R激活敏感的疾病和疾病是有用的,例如肥胖症、糖尿病、性功能障碍,包括勃起功能障碍和女性性功能障碍。
  • Bicyclic piperidine derivatives as melanocortin-4 receptor agonists
    申请人:Nargund P. Ravi
    公开号:US20060194780A1
    公开(公告)日:2006-08-31
    Certain novel bicyclic N-acylated piperidine derivatives are agonists of the human melanocortin receptor(s) and, in particular, are selective agonists of the human melanocortin-4 receptor (MC-4R). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the activation of MC-4R, such as obesity, diabetes, sexual dysfunction, including erectile dysfunction and female sexual dysfunction.
    某些新型双环N-酰化哌啶衍生物是人类黑色素细胞素受体的激动剂,特别是人类黑色素细胞素-4受体(MC-4R)的选择性激动剂。因此,它们可用于治疗、控制或预防对MC-4R激活有响应的疾病和障碍,如肥胖症、糖尿病、性功能障碍,包括勃起功能障碍和女性性功能障碍。
  • Acylated Piperidine Derivatives as Melanocortin 4-Receptor Agonists
    申请人:Barakat J. Khaled
    公开号:US20080051430A1
    公开(公告)日:2008-02-28
    Certain novel N-acylated piperidine derivatives are agonists of the human melanocortin receptor(s) and, in particular, are selective agonists of the human melanocortin-4 receptor (MC-4R). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the activation of MC-4R, such as obesity, diabetes, sexual dysfunction, including erectile dysfunction and female sexual dysfunction.
    某些新型的N-酰化哌啶衍生物是人类黑色素细胞素受体的激动剂,特别是人类黑色素细胞素-4受体(MC-4R)的选择性激动剂。因此,它们可用于治疗、控制或预防对MC-4R激活有响应的疾病和障碍,如肥胖症、糖尿病、性功能障碍,包括勃起功能障碍和女性性功能障碍。
  • Acylated piperidine derivatives as melanocortin-4 receptor modulators
    申请人:Bakshi Raman K.
    公开号:US20090253744A1
    公开(公告)日:2009-10-08
    Certain novel N-acylated spiropiperidine derivatives are ligands of the human melanocortin receptor(s) and, in particular, are selective ligands of the human melanocortin-4 receptor (MC-4R). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the modulation of MC-4R, such as obesity, diabetes, nicotine addiction, alcoholism, sexual dysfunction, including erectile dysfunction and female sexual dysfunction.
    某些新型N-酰化的螺环吡啶衍生物是人类黑色素细胞素受体的配体,特别是人类黑色素细胞素-4受体(MC-4R)的选择性配体。因此,它们可用于治疗、控制或预防对MC-4R调节敏感的疾病和障碍,如肥胖症、糖尿病、尼古丁成瘾、酗酒、性功能障碍,包括勃起功能障碍和女性性功能障碍。
  • [EN] ACYLATED PIPERIDINE DERIVATIVES AS MELANOCORTIN-4 RECEPTOR AGONISTS<br/>[FR] DERIVES DE PIPERIDINE ACYLES, UTILISES EN TANT QU'AGONISTES DU RECEPTEUR DE LA MELANOCORTINE 4
    申请人:MERCK & CO INC
    公开号:WO2006019787A3
    公开(公告)日:2006-09-14
查看更多